GGrantIndex
Sort

50,496 grants matching lung cancer

Oxidant Exposure and Related Harm from Tobacco Smoke

$464,336
John P Richie · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2019 · HL

Exploring Collateral Lethality for Development of Cancer Therapeutics

$464,312
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Phenotype Interactions and Dynamics in SCLC Tumors

$464,274
Alissa M Weaver · Vanderbilt University · U54 · FY2018 · CA

Mdm2 Alternative Splicing in DNA Damage and Cancer

$464,185
Dawn S Chandler · Ohio State University · R01 · FY2025 · CA

Quantitative Oncologic PET-MR

$464,155
Georges El Fakhri · Massachusetts General Hospital · R01 · FY2014 · CA

Imaging Feedback to Guide Ultrasonic Tissue Fractionation for Cancer Therapy

$464,137
Charles Alan Cain · University Of Michigan At Ann Arbor · R01 · FY2012 · CA

Peptides for the treatment of pulmonary fibrosis

$464,121
Carol A Feghali-Bostwick · Medical University Of South Carolina · R33 · FY2024 · HL

Peptides for the treatment of pulmonary fibrosis

$464,121
Carol A Feghali-Bostwick · Medical University Of South Carolina · R33 · FY2025 · HL

Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia

$464,065
Oleh Taratula · Oregon State University · R37 · FY2020 · CA

Chemical disruption of Wnt-mediated signal transduction

$464,007
Lawrence Lum · Ut Southwestern Medical Center · R01 · FY2016 · CA

Chemical disruption of Wnt-mediated signal transduction

$464,007
Lawrence Lum · Ut Southwestern Medical Center · R01 · FY2015 · CA

Chemical disruption of Wnt-mediated signal transduction

$464,007
James Kim · Ut Southwestern Medical Center · R01 · FY2017 · CA

Chemical disruption of Wnt-mediated signal transduction

$464,007
Lawrence Lum · Ut Southwestern Medical Center · R01 · FY2013 · CA

Lipid-Peroxidation Induced Cyclic Adducts in Hepatocarcinogenesis

$463,845
Fung-Lung Chung · Georgetown University · R01 · FY2009 · CA

Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers

$463,832
Sigrid Carlsson · Sloan-Kettering Inst Can Research · U01 · FY2022 · CA

Systems Biology of Antigen and T-Cell Transport in Cancer Immunotherapy

$463,816
Timothy P Padera · Massachusetts General Hospital · R01 · FY2024 · CA

Optimal Decision Making in Radiotherapy Using Panomics Analytics

$463,743
Issam M. El Naqa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA

Ras-mediated signals in human epithelial cell transformation and metastasis

$463,709
Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

LKB1/AMPK Signaling and Peutz-Jeghers Syndrome

$463,681
Lewis C Cantley · Brigham And Women'S Hospital · P01 · FY2007 · CA

Investigation of NRF2-Dependent Metabolic Liabilities

$463,660
Gina Marie Denicola · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2020 · CA

Understanding the effect of aging on the lung adenocarcinoma tumor microenvironment

$463,625
Alexander Minchev Tsankov · Icahn School Of Medicine At Mount Sinai · R21 · FY2025 · AG

Identifying metabolic dependencies in genetic subtypes of KRAS-driven lung cancer

$463,583
Thales Papagiannakopoulos · New York University School Of Medicine · R37 · FY2023 · CA

Intratumoral generation of F-Ade to ablate low growth fraction HNSCC

$463,582
Eric J Sorscher · Emory University · R01 · FY2017 · DE

OST Inhibition in NSCLC

$463,580
Joseph N Contessa · Yale University · R01 · FY2024 · CA

Mechanism of Intratumoral Transport of Particulate Drugs

$463,570
Haifa Shen · Methodist Hospital Research Institute · R01 · FY2021 · CA